Latest CyberKnife technology now available in Japan SUNNYVALE, Calif. , March 27, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today it received Shonin approval from the Japanese Ministry of Health, Labor and Welfare (MHLW) to market the CyberKnife® M6™ System to treat
Receives Omega's prestigious NorthFace ScoreBoard Award(SM) for exceeding customer expectations SUNNYVALE, Calif. , March 18, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today it has received the NorthFace ScoreBoard Award SM from Omega Management Group Corp .
SUNNYVALE, Calif. , Feb. 12, 2014 (GLOBE NEWSWIRE) -- Accuray Incorporated (Nasdaq:ARAY), announced today that its management is scheduled to participate in three upcoming investor conferences. Accuray management is scheduled to present at the Citi 2014 Global Healthcare Conference in New York on
SUNNYVALE, Calif. , Feb. 11, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that overall user satisfaction for its TomoTherapy ® System has increased for the fifth consecutive quarter, according to the Q4 2013 MD Buyline Market Intelligence Briefing™.
Achieves Adjusted EBITDA Profit on Revenue Growth and Margin Expansion Updates Financial Guidance SUNNYVALE, Calif. , Jan. 30, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today financial results for the second fiscal quarter and six months ended December 31, 2013 .
SUNNYVALE, Calif. , Jan. 7, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today that it will report results for its second quarter of fiscal 2014, ended December 31, 2013 on Thursday, January 30, 2014 after the market closes. A conference call to review the results will begin
SUNNYVALE, Calif. , Jan. 6, 2014 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that its management is scheduled to present at the JP Morgan 32 nd Annual Healthcare Conference in San Francisco on Monday, January 13, 2014 at 4:00 p.m. PST / 7:00 p.m. EST /.
More than 700 CyberKnife® and TomoTherapy® Systems Have Treated More Than Half a Million Patients Worldwide SUNNYVALE, Calif. , Nov. 25, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY) announced today continued momentum in global adoption of its CyberKnife® and TomoTherapy® Systems.
SUNNYVALE, Calif. , Nov. 18, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today that its management is scheduled to present at the Piper Jaffray 25 th Annual Healthcare Conference in New York on Wednesday, December 4, 2013 at 1:00 p.m. EST / 10:00 a.m. PST .
UCLA Researchers Evaluate Long-term Outcomes of More than 1,000 Patients from Multiple Institutions SUNNYVALE, Calif. , Nov. 7, 2013 /PRNewswire/ -- Accuray Incorporated (Nasdaq: ARAY), announced today the publication of two papers stemming from a large multi-center study of CyberKnife®
*The quarterly and year-end results reported herein were subsequently revised for adjustments that were immaterial, individually and in the aggregate. The revised quarterly and year-end results are included in our Annual Report on Form 10-K, filed with the Securities and Exchange Commission (the "SEC") on August 25, 2020, and are accessible on our website at https://investors.accuray.com/financial-information/sec-filings and on the SEC's website at www.sec.gov.
